ISHARES TR's ticker is IBB and the CUSIP is 464287556. A total of 644 filers reported holding ISHARES TR in Q3 2018. The put-call ratio across all filers is 1.77 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $204,509 | -21.4% | 1,566 | -17.4% | 0.07% | -37.1% |
| Q4 2022 | $260,040 | +7.0% | 1,895 | -0.2% | 0.12% | +3.6% |
| Q1 2022 | $243,000 | -19.3% | 1,898 | -19.0% | 0.11% | -8.9% |
| Q4 2021 | $301,000 | -26.0% | 2,342 | -9.3% | 0.12% | -11.5% |
| Q3 2021 | $407,000 | -8.5% | 2,583 | +0.3% | 0.14% | -14.7% |
| Q2 2021 | $445,000 | +9.6% | 2,574 | -2.1% | 0.16% | -0.6% |
| Q1 2021 | $406,000 | -1.5% | 2,628 | +5.0% | 0.16% | -4.1% |
| Q4 2020 | $412,000 | +53.2% | 2,503 | +25.0% | 0.17% | -2.8% |
| Q3 2020 | $269,000 | +29.3% | 2,002 | +32.7% | 0.18% | +44.3% |
| Q2 2020 | $208,000 | -20.0% | 1,509 | -28.7% | 0.12% | -47.9% |
| Q4 2019 | $260,000 | +11.1% | 2,117 | -0.6% | 0.23% | -3.7% |
| Q3 2019 | $234,000 | -24.8% | 2,130 | -24.1% | 0.24% | -29.6% |
| Q2 2019 | $311,000 | +32.3% | 2,807 | +29.4% | 0.34% | -7.8% |
| Q3 2018 | $235,000 | +13.5% | 2,169 | +15.2% | 0.37% | +32.6% |
| Q2 2018 | $207,000 | – | 1,883 | – | 0.28% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Elliott Investment Management L.P. | 4,617,600 | $564,686,304 | 4.37% |
| BOULDER HILL CAPITAL MANAGEMENT LP | 57,250 | $7,001,103 | 4.35% |
| DAFNA Capital Management LLC | 102,500 | $12,534,725 | 3.90% |
| Michelson Medical Research Foundation, Inc. | 43,395 | $5,306,775 | 3.58% |
| Rye Brook Capital LLC | 40,900 | $5,002 | 3.56% |
| Bronte Capital Management Pty Ltd. | 283,229 | $34,636,074 | 3.49% |
| FWL INVESTMENT MANAGEMENT, LLC | 39,504 | $4,830,944 | 3.24% |
| Alpha Family Trust | 34,568 | $4,227,321 | 3.22% |
| HARBOUR INVESTMENT MANAGEMENT LLC | 40,720 | $4,985,830 | 2.85% |
| CUMBERLAND ADVISORS INC | 51,490 | $6,296,712 | 2.79% |